NCT01877655 - A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT) | Biotech Hunter

Enrollment

514

Participants

Timeline

Start Date

September 11, 2013

Primary Completion Date

September 28, 2017

Study Completion Date

March 1, 2022

Conditions

Cytomegalovirus (CMV)-Positive RecipientsAllogeneic, Hematopoietic Cell Transplant (HCT)

Interventions

BIOLOGICAL

ASP0113

Intramuscular injection

DRUG

Placebo

Intramuscular injection

Trial Locations (83)

3000

Site BE32005, Leuven

8000

Site BE32001, Bruges

8800

Site BE32007, Roeselare

10002

Site TW88601, Taipei

10032

Site US10047, New York

11217

Site TW88602, Taipei

14004

Site ES34005, Córdoba

14186

Site SE46003, Stockholm

14642

Site US10027, Rochester

18012

Site ES34003, Granada

21201

Site US10043, Baltimore

21205

Site US10011, Baltimore

23298

Site US10031, Richmond

25030

Site FR33011, Besançon

27514

Site US10025, Chapel Hill

28028

Site ES34011, Madrid

30008

Site ES34007, Murcia

30322

Site US10012, Atlanta

33305

Site TW88603, Taoyuan

33612

Site US10030, Tampa

35294

Site US10028, Birmingham

37007

Site ES34010, Salamanca

37075

Site DE49013, Göttingen

37232

Site US10016, Nashville

39008

Site ES34002, Santander

40202

Site US10010, Louisville

40225

Site DE49012, Düsseldorf

44093

Site FR33009, Nantes

46010

Site ES34009, Valencia

46237

Site US10007, Indianapolis

48149

Site DE49007, Münster

50937

Site DE49014, Cologne

53127

Site DE49010, Bonn

53226

Site US10019, Milwaukee

55131

Site DE49015, Mainz

55905

Site US10036, Rochester

60612

Site US10013, Chicago

63110

Site US10042, St Louis

66205

Site US10020, Westwood

70376

Site DE49005, Stuttgart

72076

Site DE49008, Tübingen

75246

Site US10002, Dallas

77030

Site US10045, Houston

84143

Site US10046, Salt Lake City

85724

Site US10044, Tucson

89081

Site DE49006, Ulm

94000

Site FR33005, Créteil

94143

Site US10035, San Francisco

94305

Site US10026, Stanford

97080

Site DE49001, Würzburg

98108

Site US10039, Seattle

98109

Site US10024, Seattle

110744

Site KR82003, Seoul

02114

Site US10021, Boston

07601-2105

Site US10023, Hackensack

QLD 4029

Site AU43001, Herston

SA 5000

Site AU43004, Adelaide

V5Z 1M9

Site CA15001, Vancouver

M5G 2M9

Site CA15002, Toronto

H2W 1S6

Site CA15004, Montreal

G1R 2J6

Site CA15003, Québec

06200

Site FR33010, Nice

04103

Site DE49002, Leipzig

Unknown

Site JP81003, Nagoya

Site JP81011, Maebashi

Site JP81007, Sapporo

Site JP81010, Bunkyo-ku

Site JP81008, Chuo-ku

Site JP81009, Minato-ku

Site JP81004, Shinjuku-ku

Site JP81001, Fukuoka

Site JP81005, Fukuoka

Site JP81006, Osaka

06351

Site KR82004, Seoul

05505

Site KR82002, Seoul

137-701

Site KR82001, Seoul

08615

Site ES34001, Badalona

08041

Site ES34006, Barcelona

08908

Site ES34004, Barcelona

413 45

Site SE46001, Gothenburg

581 85

Site SE46006, Linköping

221 85

Site SE46004, Lund

901 85

Site SE46005, Umeå

All Listed Sponsors

lead

Astellas Pharma Global Development, Inc.

INDUSTRY